trial · primary record
PRA-216
Chronic Obstructive Pulmonary Disease (COPD)
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2027-09-01 |
| Primary endpoint | Incidence, nature, and severity of treatment emergent adverse events (TEAEs) and serious adverse events (SAEs) |
| Registry ID | NCT07730281 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:38:58.631Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07730281
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.